Progression of radiotherapy for brain metastases in non-small cell lung cancer
10.3760/cma.j.cn371439-20220104-00031
- VernacularTitle:非小细胞肺癌脑转移的放疗进展
- Author:
Huan JI
1
;
Juying ZHOU
;
Chenying MA
;
Xiaoting XU
;
Songbing QIN
Author Information
1. 苏州大学附属第一医院放疗科，苏州 215006
- Keywords:
Carcinoma, non-small-cell lung;
Brain metastasis;
Radiotherapy;
Molecular targeted therapy;
Antiangiogenic therapy
- From:
Journal of International Oncology
2022;49(3):181-184
- CountryChina
- Language:Chinese
-
Abstract:
Brain metastases are one of the most common distant metastases in patients with non-small cell lung cancer (NSCLC), and the prognosis will be extremely poor. The effect of chemotherapy and operation is limited. As a standard treatment, radiotherapy is widely used in clinical practice. Radiotherapy alone includes whole brain radiotherapy, stereotactic radiotherapy and whole brain radiotherapy combined with stereotactic radiotherapy. With the continuous development of radiotherapy and the progress of gene sequencing, radiotherapy has been combined with targeted drugs, anti-angiogenic drugs and immunodrugs in the treatment of NSCLC brain metastasis, which can improve the survival of patients with NSCLC brain metastasis.
